Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R F Morton

Showing results (31-40 of 61) with videos related to

Pageof 7
Sort By:
American Journal of Clinical Oncology|April 1, 1991
Phase II trial of recombinant leukocyte A interferon (IFN-alpha 2A) plus 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) and the combination cimetidine with BCNU in patients with disseminated malignant melanomaR F Morton, E T Creagan, D J Schaid, et al.
Journal of Neurosurgery|August 10, 2000
Efficacy of neuroradiological imaging, neurological examination, and symptom status in follow-up assessment of patients with high-grade gliomasE Galanis, J C Buckner, P Novotny, et al.
American Journal of Hematology|April 1, 1995
Myelodysplastic syndrome treatment with danazol and cis-retinoic acidL Letendre, R Levitt, R V Pierre, et al.
American Journal of Clinical Oncology|October 1, 1988
Evaluation of fludarabine phosphate in patients with recurrent gliomaT L Cascino, L D Brown, R F Morton, et al.
Cancer Treatment Reports|April 1, 1987
Phase II study of the combination of carmustine and 6-thioguanine in advanced malignant melanomaR F Morton, E T Creagan, M H Veeder, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|December 1, 2004
Investigating four 'myths' surrounding dysphagia in patients with metastatic esophageal cancer. A multi-institutional study from the North Central Cancer Treatment GroupA Jatoi, N Foster, P Johnson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1995
Randomized, surgical adjuvant clinical trial of recombinant interferon alfa-2a in selected patients with malignant melanomaE T Creagan, R J Dalton, D L Ahmann, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 9, 2005
PS-341 and gemcitabine in patients with metastatic pancreatic adenocarcinoma: a North Central Cancer Treatment Group (NCCTG) randomized phase II studyS R Alberts, N R Foster, R F Morton, et al.
Cancer|November 1, 1996
Phase II trials of 5-fluorouracil and leucovorin in patients with metastatic gastric or pancreatic carcinomaJ Rubin, J G Gallagher, G Schroeder, et al.
Cancer|February 15, 1994
Phase II trial of edatrexate in small cell lung cancerM Wiesenfeld, J R Jett, J Q Su, et al.
Pageof 7

Showing results (31-40 of 61) with videos related to

Sort By:
Pageof 7
American Journal of Clinical Oncology|April 1, 1991
Phase II trial of recombinant leukocyte A interferon (IFN-alpha 2A) plus 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) and the combination cimetidine with BCNU in patients with disseminated malignant melanomaR F Morton, E T Creagan, D J Schaid, et al.
Journal of Neurosurgery|August 10, 2000
Efficacy of neuroradiological imaging, neurological examination, and symptom status in follow-up assessment of patients with high-grade gliomasE Galanis, J C Buckner, P Novotny, et al.
American Journal of Hematology|April 1, 1995
Myelodysplastic syndrome treatment with danazol and cis-retinoic acidL Letendre, R Levitt, R V Pierre, et al.
American Journal of Clinical Oncology|October 1, 1988
Evaluation of fludarabine phosphate in patients with recurrent gliomaT L Cascino, L D Brown, R F Morton, et al.
Cancer Treatment Reports|April 1, 1987
Phase II study of the combination of carmustine and 6-thioguanine in advanced malignant melanomaR F Morton, E T Creagan, M H Veeder, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|December 1, 2004
Investigating four 'myths' surrounding dysphagia in patients with metastatic esophageal cancer. A multi-institutional study from the North Central Cancer Treatment GroupA Jatoi, N Foster, P Johnson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1995
Randomized, surgical adjuvant clinical trial of recombinant interferon alfa-2a in selected patients with malignant melanomaE T Creagan, R J Dalton, D L Ahmann, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 9, 2005
PS-341 and gemcitabine in patients with metastatic pancreatic adenocarcinoma: a North Central Cancer Treatment Group (NCCTG) randomized phase II studyS R Alberts, N R Foster, R F Morton, et al.
Cancer|November 1, 1996
Phase II trials of 5-fluorouracil and leucovorin in patients with metastatic gastric or pancreatic carcinomaJ Rubin, J G Gallagher, G Schroeder, et al.
Cancer|February 15, 1994
Phase II trial of edatrexate in small cell lung cancerM Wiesenfeld, J R Jett, J Q Su, et al.
Pageof 7